Sandy Draper
Stock Analyst at Guggenheim
(2.94)
# 1,587
Out of 4,918 analysts
119
Total ratings
59.38%
Success rate
20.16%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $423.09 | +2.11% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $182.45 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $166.91 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $9.98 | +240.68% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.53 | +120.75% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $57.33 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $3.73 | -46.38% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $166.44 | +58.01% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $1.70 | +1,664.71% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $91.06 | +3.23% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $6.94 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $18.86 | +170.41% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $134.58 | -4.15% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $23.64 | +132.66% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $47.76 | +251.76% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $62.55 | -80.82% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $21.27 | +78.66% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $5.39 | +827.64% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $5.16 | +1,159.69% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $3.52 | +922.73% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $281.35 | -40.64% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.44 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $13.93 | +352.26% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $423.09
Upside: +2.11%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $182.45
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $166.91
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $9.98
Upside: +240.68%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.53
Upside: +120.75%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $57.33
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $3.73
Upside: -46.38%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $166.44
Upside: +58.01%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $1.70
Upside: +1,664.71%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $91.06
Upside: +3.23%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $6.94
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $18.86
Upside: +170.41%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $134.58
Upside: -4.15%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $23.64
Upside: +132.66%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $47.76
Upside: +251.76%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $62.55
Upside: -80.82%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $21.27
Upside: +78.66%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $5.39
Upside: +827.64%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $5.16
Upside: +1,159.69%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $3.52
Upside: +922.73%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $281.35
Upside: -40.64%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.44
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $13.93
Upside: +352.26%